Pharmacokinetics of Vaginal Progesterone in Pregnancy
Status: Completed
Location: See location...
Intervention Type: Drug
Study Type: Interventional
Study Phase: Phase 1
SUMMARY
Pharmacokinetic analysis of 200mg vaginal progesterone suppository in women with singleton pregnancies between 18 0/7- 23 6/7 weeks' gestation
Eligibility
Participation Requirements
Sex: Female
Minimum Age: 18
Maximum Age: 55
Healthy Volunteers: t
View:
• ≥18 years old pregnant with singleton gestation 16 0/7 - 23 6/7 weeks
• pre-pregnancy BMI 20-40
• no history of prior preterm birth
Locations
United States
Pennsylvania
Thomas Jefferson University Hospital
Philadelphia
Time Frame
Start Date: 2017-11-06
Completion Date: 2018-06-30
Participants
Target number of participants: 6
Treatments
Other: Vaginal Progesterone
micronized progesterone vaginal suppository 200mg
Authors
Sponsors
Leads: Thomas Jefferson University